Viracta Therapeutics, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Viracta Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
  • Viracta Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.25M, a 29.6% decline year-over-year.
  • Viracta Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.25M, a 22.3% decline year-over-year.
  • Viracta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.65M, a 43.5% decline from 2022.
  • Viracta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $13.5M, a 144% increase from 2021.
  • Viracta Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.54M, a 1493% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7.65M -$5.9M -43.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 $13.5M +$8.01M +144% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 $5.54M +$5.19M +1493% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-14
2020 $348K -$280K -44.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-17
2019 $628K -$2.01M -76.2% Jan 1, 2019 Dec 31, 2019 8-K/A 2021-03-23
2018 $2.64M -$396K -13.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
2017 $3.03M -$1.76M -36.7% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 $4.79M -$1.55M -24.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-09
2015 $6.34M +$125K +2.01% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-09
2014 $6.22M +$2.33M +60.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
2013 $3.89M +$1.16M +42.6% Jan 1, 2013 Dec 31, 2013 10-K 2016-03-14
2012 $2.72M +$1.34M +96.3% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 $1.39M +$511K +58.3% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-06
2010 $877K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.